April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Praises Trade Court Decision Striking Down Trump’s Illegal Global Tariffs
- Wyden Statement on House Passage of Reconciliation Legislation
- Wyden Warns Republicans that Overruling Parliamentarian to Nix California Clean Air Waiver Will Backfire
- Wyden Statement on IRS Nominee Billy Long's Involvement in Tax Scams
- Wyden Opposes HHS Nominees O'Neill and Andres to be Deputy Secretary and Congressional Liaison